AC Immune (ACIU) Accounts Payables (2014 - 2025)

AC Immune (ACIU) has 12 years of Accounts Payables data on file, last reported at $2.6 million in Q4 2025.

• Quarterly Accounts Payables fell 14.72% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 14.72% YoY) and the FY2025 annual result came in at $2.5 million, down 17.79% from the prior year.
• Accounts Payables climbed to $2.6 million in Q4 2025 per ACIU's latest filing, from $2.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $2.2 billion in Q4 2021 and bottomed at $349904.7 in Q2 2022.
• The 5-year median for Accounts Payables is $2.3 million (2025), against an average of $254.2 million.
• The widest annual swing landed in 2022, when Accounts Payables tumbled 99.96%; it then jumped 196185.83% in 2023.
• Tracing ACIU's Accounts Payables over 5 years: stood at $2.2 billion in 2021, then plunged by 99.96% to $964322.4 in 2022, then surged by 196185.83% to $1.9 billion in 2023, then tumbled by 99.84% to $3.0 million in 2024, then slipped by 14.72% to $2.6 million in 2025.
• Per Business Quant, the three latest ACIU Accounts Payables figures stand at $2.6 million (Q4 2025), $2.0 million (Q3 2025), and $3.3 million (Q2 2025).

Peer Comparison